11
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 807-818 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • A novel peptide-grafted liposomal delivery system targeted to macrophages. BANERJEE, G., MEDoÀ, S., and BASU, M. K. Antimicrob. Agents Chemother., 1998, 42 (2), 348–351.
  • A method for determination of the specific volume of liposomes with Turnbull's Blue. LAGUEINA, L. S., STEIN, M. V. A., BONDARENKO, D. I., and SHOLTZ, K. F. Prikl. Biokhim. Mikrobiol., 1997, 33 (6), 655–659.
  • A large-scale process to produce microencapsulated proteins. HERBERT, P., MURPHY, K., JOHNSON, 0., Doc, N., JAwoaowicz, W., TRACY, M. A., CLELAND, J. L., and PUTNEY, S. D. Pharm. Res., 1998, 15 (2), 357–361.
  • Administration of liposomal agents and the phagocytic function of the mononuclear phago-cyte system. BARKER, W. I. A. J. M., TEN, K. M. T., STORM, G., and VAN ETTEN, E. W. M. Int. J. Pharm., 1998, 162 (1-2), 5–10.
  • Advances in liposomes as transdermal drug delivery system. ZHAI, G., Zou, L., and ZHANG, T., Zhongguo Yaoxue Zazhi (Beijing), 1997, 32 (6), 329–332.
  • Amphiphilic poly(Ala)-b-poly(Sar) microspheres loaded with hydrophobic drug. KIDCHOB, 'F., KINIURA, S., and INIANNHI, Y..7. Controlled Release, 1998, 51(2,3), 241–248.
  • An immune response to ovalbumin covalently coupled to liposomes is prevented when the liposomes used contain doxorubicin. TARDI, P. G., SWARTZ, E. N., HARASYM, T. 0., CULLIS, P. R., and BALLY, M. B..7. Immunol. Methods, 1997, 210 (2), 137–148.
  • An efficient liposome-mediated gene transfer into the branchial arch, neural tube and the heart of chick embryos; a strategy to elucidate the organogenesis. YAMADA, G., NAKAMURA, S., HARAGUCHI, R., SAKAI, M., TERASHI, T., SAKISAKA, S., TOYODA, T., OGINO, Y HATANAKA, H., and KANEDA, Y. Cell Mol. Biol. ( Paris), 1997, 43 (8), 1165–1169.
  • Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. LUCK, M., PAULKE, B. R., SCHRODER, W., BLUNK, T., and MULLER, R. H. J. Biomed. Mater. Res., 1998, 39 (3), 478–485.
  • Angiotensin II and related peptides alter liposomal membrane fluidity. BRAILOIU, E., MARGINEANU, A., and MIYAMOTO, M. D. Biochem. Mol. Biol. Int., 1998, 44 (1), 203–209.
  • Antioxidant activities of vitamin E derivatives in large unilamellar liposomes. KOGA, T., and TERM), J. Bitamin E Kenkyu no Shinpo, 1996, 6, 56–61.
  • Antioxidative activities of several marine polysaccharides evaluated in a phosphatidylcho-line-liposomal suspension and organic solvents. XLIE, C., Yu, G., HIRATA, T., TERAO, J., and LIN, H. Biosci. Biotechnol. Biochem., 1998, 62 (2), 206–209.
  • Antitumor effect of polysaccharide coated liposomal adriamycin on AH66 hepatoma in nude mice. ICHINOSE, K., YAMAMOTO, NI., KHOJI, T., ISHII, N., SUNAMOTO, J., and KANEMATSU, T. Anticancer Res., 1998, 18 (IA), 401–404.
  • Application of HPLC to counting of colored microspheres in determination of regional blood flow. MAzoTT, J. X., LE GUEN, R., DECAUX, A., ALBALADEJO, P., and SANIII, K. Am. J. Physiol., 1998, 274 (3 Pt 2), H1041–H1047.
  • Application of agarose microcapsules to allo-islet transplantation in a canine model. TASHIRO, H., IWATA, H., WARNOC'K, G. L., IKADA, Y., and Tsui', T. Transplant. Proc., 1998, 30 (2), 498–499.
  • Assessment of the in vivo function of pig islets encapsulated in uncoated alginate micro-spheres. TZE, W. J., CHEUNG, S. C., TAI, J., and YE, H. Transplant. Proc., 1998, 30(2), 477–478.
  • Atomic force microscopy for studying gene transfection mediated by cationic liposomes with a cationic cholesterol derivative. KAWAURA, C., NOGUCHI, A., FURUNO, T., and NAKANISIII, NI. FEBS Lett., 1998, 421 (1), 69–72.
  • Biodegradable cisplatin microspheres for direct brain injection: preparation and character-ization. GARCIA, C. L., ABU, I. K., and Lu, D. R. Pharm. Dev. Technol., 1997, 2 (1), 53–65.
  • Biological response modifiers: interferons, interleukins, recombinant products, liposomal products. KauTit, S. A. Vet. Clin. North Am. Small Anim. Pract., 1998, 28 (2), 269–95. 111 Refs.
  • Bordetella pertussis filamentous hemagglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally. POULAIN, G. 0., MIELCAREK, N., IVANOFF, N., RENIOUE, F., SCHACHT, A. M., PHILLIPS, N., LOCHT, C., CAPRON, A., and RIVEAU, G. Infect. Immun., 1998, 66 (4), 1764–1767.
  • Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome). WEITKAMP, J. H., POETS, C. F., SIEVERS, R., 0265-2048/98 1112-00 (e) 1998 Taylor & Francis Ltd. MUSSWESSELS, E., GRONECK, P., THOMAS, P., and BARTMANN, P. Infection ( Munich ), 1998, 26 (1), 15–19.
  • Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. THURSTON, G., MCLEAN, J. W., RIZEN, M., BAI.UK, P., HASKELL, A., MURPHY, T. J., HANAHAN, D., and MCDONALD, D. M. J. Clin. Invest., 1998, 101 (7), 1401–1413.
  • Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins. Qiu, C., DE YOUNG, M. B., FINN, A., and DICHEK, D. A. Hum. Gene Ther., 1998, 9 (4), 507–520.
  • Characterization of a pH-sensitive surfactant, dodecy1-2-(1'-imidazoly1) propionate (DIP), and preliminary studies in liposome mediated gene transfer. LIANG, E., and HUGHES, J. Biochim. Biophys. Acta, 1998, 1369 (I), 39–50.
  • Characterization and trypanocidal activity of nifurtimox-containing and empty nano-particles of polyethylcyanoacrylates. GONZALEZ, M. G., MERINO, I., RODRIGUEZ, C. M. N., TORRES, M., NUNEZ, R., and OSUNA, A. 7. Pharm. Pharmacol., 1998, 50 (1), 29–35.
  • Charge-induced chromatic transition of amino acid-derivatized polydiacetylene liposomes. CHENG, Q., and STEVENS, R. C. Langmuir, 1998, 14 (8), 1974–1976.
  • Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model. CABANES, A., TZEMACH, D., GOREN, D., HOROWITZ, A. T., and GABIZON, A. Clin. Cancer Res., 1998, 4 (2), 499–505.
  • Comparison of intraurethral liposomal and intracavernosal prostaglandin-El in the manage-ment of erectile dysfunction. ENGELHARDT, P. F., PLAS, E., HUBNER, W. A., and PFLUGER, H. Br. J. Urol., 1998, 81(3), 441–444.
  • Comparison of singlet oxygen deactivation effects of alpha-tocopherol and beta-carotene in liposomal membrane and in ethanol solution. FUKUZAWA, K., IcAmi, Y., UEDA, M., TOKUMURA, A., Suzuxi, A., and TERAO, J. Bitamin E Kenkyu no Shinpo, 1998, 8, 88–94.
  • Comparison between intratracheal and intravenous administration of liposome-DNA com-plexes for cystic fibrosis lung gene therapy. GRIESENBACH, U., CHONN, A., CASSADY, R., HANNAM, V., ACKERLEY, C., POST, M., TRANSWEI.L, A. K., OLEK, K., 0-BR0oovicH, H., and Tsui, L. C. Gene Ther., 1998, 5 (2), 181–188.
  • Control of permeation of lanthanide ions across phosphate-functionalized liposomal mem-branes. SCRIMIN, P., TECILLA, P., Moss, R. A., and BRACKEN, K. J. Am. Chem. Soc., 1998, 120 (6), 1179–1185.
  • COPII-coated vesicle formation reconstituted with purified coat proteins and chemically defined liposomes. MATSUOKA, K., ORCI, L., AMHERDT, M., BEDNAREK, S. Y., HAMAMOTO, S., SCHEKMAN, R., and YEUNG, T. Cell, 1998, 93 (2), 263–275.
  • Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/SCID mouse model. EGILNIEZ, N. K., JoNo, Y. S., IWANUNIA, Y., JACOB, J. S., SANTOS, C. A., CHEN, F. A., m —ATHIOWITZ, E., and BANKERT, R. B. Cancer Immunol. Immunother., 1998, 46 (1), 21–24.
  • D-myo-Inositol derivatives alter liposomal membrane fluidity. BRAILOIU, E., MARGINEANU, A., TOMA, C. P., FILIPEANU, C. M., Rusu, V., and BRANISTEANU, D. D. Biochem. Mol. Biol. Int., 1998, 44 (I), 195–201.
  • Delivery of recombinant gene product to canines with nonautologous microencapsulated cells. PEIRONE, M. A., DELANEY, K., KWIECIN, J., FLETCH, A., and CHANG, P. L. Hum. Gene Ther., 1998, 9 (2), 195–206.
  • Delivery of hydrocortisone from liposomal suspensions to the hairless mouse skin following topical application under non-occlusive and occlusive conditions. Kim, M. K., CHUNG, S. J., LEE, M. H., and SHIM, C. K. J. Microencapsulation, 1998, 15 (1), 21–29.
  • Design of microencapsulated chitosan microspheres for colonic drug delivery. LORENZO, L. M. L., REMUNAN, L. C., VILA, J. J. L., and ALONSO, M. J. y. Controlled Release, 1998, 52 (1,2), 109–118.
  • Determination of the pharmacokinetics of some oral antibiotics incorporated into gelatin microspheres after administration to rabbits. MIRON, M., and LEUCUTA, S. E. Clujul. Med., 1997, 70 (3), 472–476.
  • Development of reinforced microcapsules for maintenance control function of valid com- ponent. KIYAMA, K., and YONEMOTO, T. Kemikaru Enjiniyaringu, 1998, 43 (3), 169–175.
  • Development of in-vitro evaluation of sustained-release meclofenamic acid microspheres. KHIDR, S. H., NIAZY, E. M., and EL SAVED, Y. M. y. Microencapsulation, 1998, 15(2), 153–162.
  • Development and scale-up of a microsphere protein delivery system. TRACY, M. A. Biotechnol. Prog., 1998, 14(1), 108–115. 34 Refs.
  • Development of liposomal amphotericin B formulation. GULATI, M., BAJAD, S., SINGH, S., FERDOUS, A. J., and SINGH, M. J. Microencapsulation, 1998, 15 (2), 137–151.
  • Differential short-term distribution of estrone and oleoyl-estrone administered in liposomes to lean and obese Zucker rats. BALADA, F., SANCHIS, D., GRASA, M. M., VIRGILI, J., ESTRUCH, J., FERNANDEZ, L. J. A., REMESAR, X., and ALEMANY, M. Obes. Res., 1998, 6 (1), 34–39.
  • Dimple evolution in foam films of liposome (DPPC) suspensions. MITE, D. J., TSEKOV, R., and VASSILIEFF, C. S. Colloids Surf., B, 1997, 10 (2), 67–72.
  • Disseminated neonatal Trichosporon beigelii infection: successful treatment with liposomal amphotericin B. SWEET, D., and REID, M. J. Infect., 1998, 36 (1), 120–121.
  • Dithiocarbamate-incorporated monodisperse polystyrene microspheres as specific sorbents: adsorption of organomercury species. SAY, R., SATIROOLU, N., PISKIN, E., BEKTAS, S., and GENC, 0. Anal. Lett., 1998, 31(3), 511–528.
  • Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system. STORM, G., TEN, K. M. T., WostoNc;, P. K., and BAKKER, W. 1. A. J. M. Clin. Cancer Res., 1998, 4(1), 111–115.
  • Doxorubicin-loaded gelatin microspheres: preparation and physicochemical evaluation. AuHim, M., GfuznAvu, L., and LEUCUTA, S. E. Clujul. Med., 1997, 70 (3), 482–487.
  • Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations. THOMASIN, C., Ho, N. T., MERKLE, H. P., and GANDER, B. J. Pharm. Sci., 1998, 87 (3), 259–268. 104 Refs.
  • Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation. THOMASIN, C., MERKLE, H. P., and GANDER, B. J. Pharm. Sci., 1998, 87 (3), 269–275.
  • Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. HEIATI, H., TAWASHI, R., and PHILLIPS, N. C. J. Microencapsul., 1998, 15 (2), 173–184.
  • Dual radiolabeled liposomes: biodistribution studies and localization of focal sites of infec-tion in rats. AWASTHI, V. D., GoiNs, B., KLIPPER, R., and PHILLIPS, W. T. Nucl. Med. Biol., 1998, 25 (2), 155–160.
  • Effect of interparticulate interaction on release kinetics of microsphere ensembles. Wu, X. Y., ESHUN, G., and ZHou, Y. J. Pharm. Sci., 1998, 87 (5), 586–593.
  • Effect of bovine serum on the phase transition temperature of cholesterol-containing lipo-somes. GABER, M. H. J. Microencapsulation, 1998, 15 (2), 207–214.
  • Effect of cycloinulohexaose with additives on the freeze-drying of liposome. OZAKI, K., and HAYASHI, M. Int. J. Pharm., 1998, 160 (2), 219–227.
  • Effect of liposome-encapsulated alpha- or beta-interferon on breast cancer cell lines. CORADINI, D., PELLIZZARO, C., BIFFI, A., LOMBARDI, L., PIRRONELLO, E., RIVA, L., and Di FRONZO, G. Anticancer Res., 1998, 18 (IA), 177–182.
  • Effect of liposome-encapsulated meso-2,3-dimercaptosuccinic acid on mice exposed to lead through drinking water. MISRA, M., and BEFIARI, J. R. Boll. Chim. Farm., 1997, 136 (10), 611–614.
  • Effect of protein on the antioxidant activity of phenolic compounds in a lecithin-liposome oxidation system. HEINONEN, M., REIN, D., SA'rUE, G. M. T., HUANG, S. W., GERMAN, J. B., and FRANKEL, E. N. y. Agric. Food Chem., 1998, 46 (3), 917–922.
  • Effect of water-based microencapsulation on protection against EDIM rotavirus challenge in mice. MOSER, C. A., SPEAKER, T. J., and OFFIT, P. A. J. Virol., 1998, 72 (5), 3859–3862.
  • Effect of poly(styrene) microspheres modified with phosphorylcholine or sugar moiety onto their surface on the growth of Bacillus subtilis or Saccharomyces cerevisiae. SUGIYAMA, K., KUWAZIMA, E., SHIRAISHI, K., and SHINTANI, Y Kinki Daigaku Kogakubu Kenkyu Hokoku, 1997, 31, 67–74.
  • Effect of the slimming agent oleoyl-estrone in liposomes on the body weight of rats fed a cafeteria diet. BALADA, F., SANCHIS, D., VIRGIL, J., GRASA, M. M., MONSERRAT, C., FERNANDEZ, L. J. A., REMESAR, X., and ALEMANY, M. Arch. Physiol. Biochem., 1997, 105 (5), 487–495.
  • Effectiveness of islets microencapsulated with barium-crosslinked alginate for immunoiso-lative transplantation of xenogenic graft. NOGUCHI, A. Sei Marianna Ika Daigaku Zasshi, 1997, 25 (5), 739–748.
  • Effects of free, and liposomized praziquantel on the surface morphology and motility of Mesocestoides vogae tetrathyridia (syn. M. corti; Cestoda: Cyclophyllidea) in vitro. HRCKOVA, G., VELEBNY, S., and CORSA, J. Parasitol. Res., 1998, 84 (3), 230–238.
  • Effects of microcapsulated docosahexaenoic acid preparation on properties of dough and bread. MORITA, N., and SHIRAI, J. J. Nutr. Sci. Vitaminol. (Tokyo), 1997, 43 (5), 591–600.
  • Effects of sevoflurane on nitric oxide-dependent vasodilation. /n vivo study using radioactive microspheres. MIZUMOTO, K. junkan Seigyo, 1997, 18 (3), 352–358.
  • Electrostatic charge and particle size analysis of poly(m-lactide-co-glycolide) microspheres formulated for dry powder aerosols. PHILIP, V. A., MEHTA, R. C., DELUCA, P. P., and MAZUMDER, M. K. Part. Sci. Technol., 1997, 15 (3), 245–261.
  • Embolization with gelatin-impregnated microspheres. WEIN, B. B., and GUNTHER, R. W. Rofo. Fortschr. Geb. Rontgenstr. Neuen. Bildgeb. Verfahr., 1998, 168 (2), 171–174.
  • Enhanced treatment of peritoneal carcinomatosis using 5-fluorouracil microspheres. YANIASAKI, J., HAGIWARA, A., SAKAKURA, C., SHIRASU, M., TOGAWA, T., SONOYAN1A, Y., and TAKAHASHI, T. Kyoto furitsu Ika Daigaku Zasshi, 1998, 107 (2), 223–226.
  • Enhancement in therapeutic effects of leuprorelin acetate by sustained-release using the biodegradable microsphere injections. OKADA, H. Igaku no Ayumi, 1998, 184 (5), 314–319.
  • Enhancement of antitumor activity and reduction of adverse reactions by injection of liposomes entrapping doxorubicin or daunorubicin. OKOCHI, H., and NAKANO, M. Igaku no Ayumi, 1998, 184 (5), 320–324.
  • Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites. AKIYAMA, Y., NAGAHARA, N., NARA, E., KITANO, M., IIA'ASA, S., YAMANIOTO, I., AZUNIA, J., and OGAWA, Y..7. Pharm. Pharmacol. 1998, 50 (2), 159–166.
  • Evaluation of PLGA microsphere size effect on myotoxicity using the isolated rodent skeletal muscle model. BRAZEAU, G. A., SCIAME, M., AL-SUWAYEH, S. A., and FATTAL, E. Pharm. Dev. Technol., 1996, 1(3), 279–283.
  • Evaluation of the microparticle enzyme immunoassay Abbott IMx Select Chlamydia and the importance of urethral site sampling to detect Chlamydia trachomatis in women. BROKENSHIRE, M. K., SAY, P. J., VAN VONNO, A. H., and WONG, C. Genitourin. Med., 1997,73 (6), 498–502.
  • Experimental pulmonary delivery of cyclosporin A by liposome aerosol. WALDREP, J. C., ARPPE, J., JANSA, K. A., and VIDGREN, M. Int.Pharm., 1998, 160 (2), 239–250.
  • Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases. CABRIALES, S., BRESNAHAN, J., TESTA, D., ESPINA, B. M., SCADDEN, D. T., Ross, M., and GILL, P. S. Oncol. Nurs. Forum, 1998, 25 (1), 67–70.
  • Fabrication of PZT microspheres for application in electrorheological fluids. WEN, W., TAN, W. Y., and SHENG, P.1. Mater. Sci. Lett., 1998, 17 (5), 419–421.
  • Factors in success and failure of microencapsulated pancreatic islets. VAN SCHILFGAARDE, R., and DE VOS, P. Transplant Proc., 1998, 30 (2), 501–502.
  • Fetal sheep adrenal blood flow responses to hypoxemia after splanchnicotomy using fluor-escent microspheres. BUCHWALDER, L. F., LIN, M., MCDONALD, T. J., and NATHANIELSZ, P. W. y. Appl. Physiol., 1998, 84 (1), 82–89.
  • Flow cytometric analysis of cellular changes in mice after intradermal inoculation with a liposome-iscom adjuvanted vaccine. SAN, G. F., TURNER, B., MULLBACHF.R, A., WALKER, M. J., DJ0RDJEV1C, S. P., EANIENS, G. J., and CHIN, J. C. Scand. y. Irnmunol., 1998, 47 (3), 243–253.
  • Fluid-bed microencapsulation of ascorbic acid. KNEZEVIC, Z., GOSAKI, D., HRASTE, M., and JALSENJAK, 1.7. Microencapsulation, 1998, 15 (2), 237–252.
  • Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. GOHEL, M. C., and AMIN, A. F..7. Controlled Release, 1998, 51(2,3), 115–122.
  • Frost resistance of antiwashout underwater concrete containing expanded plastic micro-spheres and blast-furnace slag. NANAUMI, T., AYUTA, K., and YANIAKAWA, T. Semento, Konkurito Ronbunshu, 1997, 51, 90–95.
  • Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis. BRUNO, M. J., BORN, J. J. J., HOER, F. J., DELZENNE, B., HOFNIANN, A. F., DE GOE1J, J. J. M., VAN ROYEN, E. A., VAN LEEUWEN, D. J., and TrrGAT, G. N. J. Dig. Dis. Sci., 1998, 43 (1), 203–213.
  • Gene transduction for disseminated intraperitoneal tumor using cationic liposomes contain-ing non-histone chromatin proteins: cationic liposomal gene therapy of carcinoma-tosa. NAMIK1, Y., TAKAHASHI, T., and OHNO, T. Gene Ther., 1998, 5 (2), 240–246.
  • Gene transfer into eukaryotic cells using non-cationic (neutral) liposomes. ZriDANov, R. I., BUNEEVA, 0. A., PODOBED, 0. V., KUTSENKO, N. G., TSVETKOVA, T. A., and LAVRENOVA, T. P. Vopr. Med. Khim., 1997, 43 (4), 212–216.
  • Glycoprotein excreted by Pseudoalteromonas antarctica NF3 as a coating and protective agent of liposomes against sodium dodecyl sulfate. DE LA MAZA, A., PARKA, J. L., SABES, M., CONGREGADO, F., BOZAL, N., and GUINEA, J. Langmuir, 1998, 14 (1), 42–48.
  • Graft copolymers having hydrophobic backbone and hydrophilic branches. XIX. /n situ synthesis and the catalytic properties of platinum colloids on polystyrene micro-spheres with surface-grafted poly(N-isopropylacrylamide). CHEN, C. W., CHEN, M. Q., SERIZAWA, T., and AKASHI, M. Chem. Commun. (Cambridge), 1998, (7), 831–832.
  • Growth and survival of renal failure rats that received oral microencapsulated genetically engineered E. coli DH5 cells for urea removal. PRAKASH, S., and CHANG, T. M. Artif. Cells Blood Substit. Immobil. Biotechnol., 1998, 26 (1), 35–51.
  • Hemolytic and antifungal activity of liposome-entrapped amphotericin B prepared by the precipitation method. KIM, J. C., LEE, E. 0., KIM, J. Y., BAE, S. K., Cool, T. B., and KIM, J. D. Pharm. Dev. Technol., 1997, 2 (3), 275–284.
  • Hepatic immunopotentiation by galactose-entrapped liposomal IL-2 compound in the treat-ment of liver metastases. OKUNO, K., NAKAMURA, K., TANAKA, A., YACHI, K., and YASUTOMI, M. Stag. Today, 1998, 28 (1), 64–69.
  • High-resolution spectra of liposomes using MAS NMR. The case of intermediate-size vesicles. TRAIKIA, M., LANGLAIS, D. B., CANNAROZZI, G. M., and DEVAUX, P. F. J. Magn. Reson., 1997, 125 (1), 140–144.
  • Hydration of polyethylene glycol-grafted liposomes. TiRosil, 0., BARENHOLZ, Y., KATZHENDLER, J., and PRIEV, A. Biophys. . 7., 1998, 74 (3), 1371–1379.
  • Immobilization of glucoamylase onto activated pHEMA/EGDMA microspheres: properties and application to a packed-bed reactor. ARICA, M. Y., ALAEDDINOGLU, N. G., and HASIRCI, V. Enzyme Microb. Technol., 1998, 22 (3), 152–157.
  • Immunogenicity and antitumor activity of a liposomal MUC1 peptide-based vaccine. SAMUEL, J., BunzyNsm, W. A., REDDISH, M. A., DING, L., ZIMMERMANN, G. L., KRANTZ, M. J., KOGANTY, R. R., and LONC;ENECKER, B. M. Int. J. Cancer, 1998, 75 (2), 295–302.
  • In vivo liposome-mediated transfection of HLA-DR alpha-chain gene into pig hearts. ALEKSIC, 1., REN, M., POPOV, A., FREIMARK, D., BLANCHE, C., CZER, L., TRENTO, A., and BARATH, P. Eur. y. Cardiothorac. Surg., 1997, 12 (5), 792–797.
  • In vivo targeting of surface-modified liposomes to metastatically growing colon carcinoma cells and sinusoidal endothelial cells in the rat liver. SCHERPHOF, G. L., KAMPS, J. A. A. M., and KoNING, G. A..7. Liposome Res., 1997, 7 (4), 419–432.
  • In vivo tumoricidal effect of T lymphocytes activated by liposomes containing adriamycin on chemically-induced rat malignant fibrous histiocytoma. YAKUSHIJI, T., YONEMURA, K., NISHIDA, K., and TAKAGI, K. Anticancer Res., 1997, 17 (6D), 4347–4354.
  • In vitro gene transfer in mammalian cells via a new cationic liposome formulation. KAO, M. C., LAW, S. L., CHUANG, T. C., and LIN, Y. S. Oncol. Rep., 1998, 5 (3), 625–629.
  • In vivo gene transfer into the adult mammalian central nervous system by continuous injection of plasmid DNA-cationic liposome complex. ImAoKA, D. I., OHMOTO, T., YAsuni, T., and TSUDA, M. Brain Res., 1998, 780 (1), 119–128.
  • In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against Gram-negative and Gram-positive bacteria. BEAULAC, C., SACHETELLI, S., and LAGACE, J. J. Antimicrob. Chemother., 1998, 41(1), 35–41.
  • Incorporation and release of vancomycin from poly(m-lactide-co-glycolide) microspheres. A'I'KINS, T. W., PEACOCK, S. J., and YATES, D. J. J. Microencapsulation, 1998, 15 (1), 31–44.
  • Increase in sarcolysin antitumor activity by transforming it into a lipid derivative and incorporation in the membrane of liposomes containing a carbohydrate vector. KozLov, A. M., KORCHAGINA, E. Y., VODOVOZOVA, E. L., BoviN, N. V., MOLOTKOVSKII, Y. G., and SYRKIN, A. B. Bull. Exp. Biol. Med., 1997, 123 (4), 381–383.
  • Increased activation of protein kinase C with cubic phase lipid compared with liposomes. GloRG:()NE, J. R., HUANG, Z., and EPAND, R. M. Biochemistry, 1998, 37 (8), 2384–2392.
  • Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents. Wu, J., Liu, P., ZHU, J. L., MADDUKURI, S., and ZERN, M. A. Hepatology ( Philadelphia), 1998, 27 (3), 772–778.
  • Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis. LACASSE, F. X., FILION, M. C., PHILLIPS, N. C., ESCHER, E., MCMULLEN, J. N., and HILDC;EN, P. Pharm. Res., 1998, 15 (2), 312–317.
  • Influence of chitosan microspheres on the transport of prednisolone sodium phosphate across HT-29 cell monolayers. MOOREN, F. C., BERTHoi.n, A., DOMSCHKE, W., and KREUTER, J. Pharm. Res., 1998, 15 (1), 58–65.
  • Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. WITSCHI, C., and DOELKER, E..7. Controlled Release, 1998, 51(2,3), 327–341.
  • Influence of swelling degree on release of nicardipine hydrochloride from acrylic micro-spheres prepared by solvent evaporation method. YUKSEL, N., DINC, E., ONUR, F., and BAYKARA, T. Pharm. Dev. Technol., 1998, 3(1), 115–121.
  • Inhibition of influenza virus replication by phosphorothioate and liposomally endocapsulated oligonucleotides. Al3E, T., HATTA, T., TAKAI, K., NAKASHIMA, H., YOKOTA, T., and TAKAKU, H. Nucleosides Nucleotides, 1998, 17 (1-3), 471–478.
  • Inhibition of mouse mammary carcinoma development with doxorubicin in liposomes. VAAGE, J., WORKING, P., and USTER, P. Int. J. Cancer, 1998, 75 (1), 158–159.
  • Interaction between G-Actin and various types of liposomes: A 19F, 31P, and 2H nuclear magnetic resonance study. BOUCHARD, M., PARE, C., DUTASTA, J. P., CHAUVET, J. P., GICQUAUD, C., and AUGER, M. Biochemistry, 1998, 37 (9), 3149–3155.
  • Interaction of recombinant human bone morphogenetic protein-2 with poly(D, L lactide-co-glycolide) microspheres. DUGGIRALA, S. S., MEHTA, R. C., and DELucA, P. P. Pharm. Dev. Technol., 1996, 1(1), 11–9.
  • Interaction of activated leukocytes with polymeric microspheres. AYHAN, H., and PISKIN, E. ml. .7. Artif. Organs, 1997, 20 (12), 704–707.
  • Interaction of colistin with lipids in liposomes and monolayers. MESTRES, C., ALSINA, M. A., BUSQUETS, M. A., MURANYI, I., and REIG, F. Int. J. Pharm., 1998, 160 (1), 99–107.
  • Interaction of Doxorubicin with phospholipid monolayer and liposomes. GABER, M. H., GHANNAM, M. M., ALI, S. A., and KHALIL, W. A. Biophys. Chem., 1998, 70 (3), 223-229. Interaction of recombinant interleukin-2 with liposomal bilayers. KOPPENHAGEN, F. J., VISSER, A. J. W. G., HERRON, J. N., STORM, G., and CROMMELIN, D. J.•Pharm. Sci., 1998, 87 (6),707–714.
  • Interactions of cyclodextrins with DPPC liposomes. Differential scanning calorimetry studies. Nistiuo, J., and MIZUNO, H. Chem. Pharm. Bull. ( Tokyo), 1998, 46 (1), 120–124.
  • Introduction of DNA into the rat and primate trabecular meshwork by fusogenic liposomes. HANGAI, M., TANIHARA, H., HONDA, Y., and KANEDA, Y. Invest. Ophthalmol. Vis. Sci., 1998, 39 (3), 509–516.
  • Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon. TEN HAGEN, T. L., VAN VIANEN, W., SAVELKOUL, H. F., HEREMANS, H., BUURMAN, W. A., and BARKER WOUDENBERG, I. A. Infect. Immun., 1998, 66 (5), 1962–1967.
  • Kinetics of accumulation of molecules into liposomes. CEH, B., and LASIC, D. D. y. Phys. Chem. B, 1998, 102 (16), 3036–3043.
  • Lateral diffusion of the total polar lipids from Thermoplasma acidophilum in multilamellar liposomes. JARRELL, H. C., ZUKOTYNSKI, K. A., and SPROTT, G. D. Biochim. Biophys. Ada, 1998, 1369 (2), 259–266.
  • Lipopolysaccharide and liposome-encapsulated MTP-PE-induced cytotoxicity and release of eicosanoids, tumor necrosis factor-.alpha. and nitric oxide in liver macrophages. DIETER, P., AMBS, P., FITZKE, E., and SCHWENDE, H. Adv. Exp. Med. Biol., 1997, 407 (Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 3), 485–490.
  • Liposomal doxorubicin in pulmonary Kaposi's sarcoma. Improved survival as compared to patients without liposomal doxorubicin. GRUENAUG, M., BOGNER, J. R., LOCH, 0., and GOEBEL, F. D. Eur. y. Med. Res., 1998, 3 (1/2), 13–19.
  • Liposomal delivery of a 30-mer antisense oligodeoxynucleotide to inhibit proopiomelano-cortin expression. FRESTA, M., CHILLEMI, R., SPAMPINATO, S., SCIUTO, S., and Puci.isi, G. y. Pharm. Sci., 1998, 87 (5), 616–625.
  • Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity. KWAK, L. W., PENNINGTON, R., BONI, L., OCHOA, A. C., ROFIB, R. J., and PopEscu, M. C. y. Immunol., 1998, 160 (8), 3637–3641.
  • Liposomal amphotericin B treatment for neonatal fungal infections. SCARCELLA, A., PASQUA-RIELLO, M. B., GIUGLIANO, B., VENDEMMIA, M., and DE LUCIA, A. Pediatr. Infect. Dis. y., 1998, 17 (2), 146–148.
  • Liposomal-encapsulated muramyl tripeptide phosphatidylethanolamine for treatment of pulmonary metastasis from osteosarcoma. YING, M. Zhongguo Yaolixue Tongbao, 1997, 13 (3), 207–209.
  • Liposome encapsulated hemoglobin as a resuscitation fluid for hemorrhagic shock. UsuBA, A., OSUKA, F., KIMURA, T., SATO, R., FUJITA, Y., YAMASHITA, M., and HOSHINO, C. Art if. Organs, 1998, 22 (2), 116–122.
  • Liposome-catalyzed unfolding of acetylcholinesterase from Bungarus fasciatus. SHIN, I., SIT-MAN, I., BON, C., and WEINER, L. Biochemistry, 1998, 37 (13), 4310–4316.
  • Liposome-mediated enhancement of the sensitivity in immunoassays of proteins and pep-tides in surface plasmon resonance spectrometry. WINK, T., VAN ZUILEN, S. J., Bui.T, A., and VAN BENNEKONT, W. P. Anal. Chem., 1998, 70 (5), 827–832.
  • Liposome-mediated drug targeting in topical and regional therapies. MARGALIT, R. Grit. Rev. Ther. Drug Carrier Syst., 1995, 12(2–3), 233–261. 154 Refs.
  • Liposome-mediated gene transfer. YANAGIHARA, I., KANEDA, Y., INui, K., and OKADA, S. MO/. Cell Biol. Hum. Dis. Ser., 1995, 5, 64–82. 37 Refs.
  • Liposomes in radiology and nuclear medicine. Diagnostic imaging and therapy. OGIHARA, U. I. Radioisotopes, 1998, 47 (3), 287–289.
  • Liposomes with vitamin A, C, and E. BLUME, G., HERRLING, T., STRODTHOLZ, I., and TEICHMUELLER, E. E. Parfuem. Kosmet., 1998, 79 (1–2), 8–10.
  • Local treatment of prosthetic vascular graft infection with multivesicular liposome-encap-sulated amikacin. HUH, J., CHEN, J. C., FURMAN, G. M., MALKI, C., KING, B., KAFIE, F., and WILSON, S. E..7. Surg. Res., 1998, 74 (1), 54–58.
  • Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations. GRIFFITHS, G. D., BAILEY, S. C., HAMBROOK, J. L., and KEYTE, M. P. Vaccine, 1998, 16 (5), 530–535.
  • Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. IV. Fate of liposomes in regional lymph nodes. OUSSOREN, C., VELINOVA, M., SCHERPHOF, G., VAN DER WANT, J. J., VAN ROOIJEN, N., and STORM, G. Biochim. Biophys. Acta, 1998, 1370 (2), 259–272.
  • Magnetic starch microspheres in the MR imaging of hepatic metastases. A preclinical study in the nude rat. SUNDIN, A., WANG, C., ERICSSON, A., and FAHLVIK, A. K. Acta Radiol., 1998, 39 (2), 161–166.
  • Manufacture of microcapsules by coagulation. WANG, X. Zhengzhou Liangshi Xueyuan Xuebao, 1997, 18 (3), 29–34.
  • Manufacturing microcapsules by encapsulation of a solid dispersion system of artemisinin. NGUYEN, D. H., NGUYEN, V. L., and NGUYEN, N. D. Tap. Chi. Duoc. Hoc., 1997, (10), 19–22.
  • Mechanism of transient dyspnea induced by pegylated-liposomal doxorubicin (DoxiITM). SKUBITZ, K. M., and SKUBITZ, A. P. N. Anti-Cancer Drugs, 1998, 9 (1), 45–50.
  • Microencapsulation of ketorolac tromethamine by means of a coacervation-phase separation technique induced by the addition of non-solvent. GENC, L., DEMIREL, M., GULER, E., and HEGAZY, N. y. Microencapsulation, 1998, 15 (1), 45–53.
  • Microencapsulation improves viability of islets from CSK miniature swine. TASHIRO, H., IWATA, H., TANIGAWA, M., TSUTSUMI, H., FUSEYA, Y., IKADA, Y., and TSUJI, T. Transplant. Proc., 1998, 30(2), 491.
  • Microencapsulation of antimicrobial ceftiofur drugs. BODMEIER, R., CHEN, H., DAVIDSON, R. G., and HARDEE, G. E. Pharm. Dev. Technol., 1997, 2 (4), 323–334.
  • Microsphere embolism-induced changes in noradrenaline release in the cerebral cortex in rats. HAYASHI, H., SATO, K., KURUHARA, Y., and TAKEO, S. Brain Res., 1998, 783 (2), 241–248.
  • Microsphere uptake by the intestine of White Leghorn chickens. PORTER, R. E. JR., SUCKOW, M. A., MACRI, N. P., and BOWERSOCK, T. L. Avian. Dis., 1997, 41(4), 981–987.
  • Microsphere-induced bronchial artery vasodilation: role of adenosine, prostacyclin, and nitric oxide. PEARSE, D. B., DAHMS, T. E., and WAGNER, E. M. Am. y. Physiol., 1998, 274(3 Pt 2), H760—H768.
  • Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. HEDLEY, M. L., CURLEY, J., and URBAN, R. Nat. Med., 1998, 4 (3), 365–368.
  • Microspheres as a drug delivery system in cancer therapy. CUMMINC;S, J. Expert Opin. Ther. Pat., 1998, 8(2), 153–171.
  • Microspheres. WILENSKY, R. L., and MARCH, K. L. Semin. Interv. Cardiol., 1996, 1(1), 48–50.
  • Model studies directed toward the application of boron neutron capture therapy to rheuma-toid arthritis: boron delivery by liposomes in rat collagen-induced arthritis. WATSON, C. R. A., BANQUERIGO, M. L., SHELLY, K., HAWTHORNE, M. F., and BRAHN, E. Proc. Natl. Acad. Sci. USA, 1998, 95 (5), 2531–2534.
  • Modification of inflammatory cytokine production in whole blood by liposome-encapsulated hemoglobin. IKEBUCHI, K., NIWA, K., FUJIHARA, M., ABE, H., WAKAMOTO, S., ITo, T., YAMAGUCHI, M., and SEKIC;UCHI, S. 'ink() Ketsueki, 1998, 6 (1), 13–16.
  • Morphological observations on liposomes bearing covalently bound protein: studies with freeze-fracture and cryo electron microscopy and small angle X-ray scattering techniques. SKALKO, N., BOUWSTRA, J., SPIES, F., STUART, M., FREDERIK, P. M., and GREGOR-[ADIS, G. Biochim. Biophys. Acta, 1998, 1370 (1), 151–160.
  • New chelate-forming polymer microspheres carrying dyes as chelators for iron overload. DENIZLI, A., SA1.111, B., and PISKIN, E. J. Biomater. Sci., Polym. Ed., 1998, 9 (2), 175–187.
  • Novel methods of microparticulate production: application to drug delivery. REYDERMAN, L., and STAVCHANSKY, S. Pharm. Dev. Technol., 1996, 1(3), 223–229.
  • Novel technology for the preparation of sterile alginate-poly-l-lysine microcapsules in a bioreactor. ABRAHAM, S. M., VIETH, R. F., and BURGESS, D. J. Pharm. Dev. Technol., 1996, 1 (1), 63–68.
  • Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy. ARONSOHN, A. I., and HUGHES, J. A..7. Drug Targeting, 1998, 5 (3), 163–169.
  • Opening-up of liposomal membranes by talin. SAITOH, A., TAKIC;UCHI, K., TANAKA, Y., and HO'FANI, H. Proc. Natl. Acad. Sci. USA, 1998, 95 (3), 1026–1031.
  • Optimization on the condition of liposome-mediated transfection to COS-7 cell line. Hu, Z., XING, G., and HE, F. junshi Yixue Kexueyuan Yuankan, 1997, 21(2), 125–127.
  • PDLLA microspheres containing steroids: spray-drying, o/w and w/o/o/w emulsification as preparation methods. GIUNCHFAH, P., ALPAR, H. 0., and CONTE, U. J. Microencapsulation, 1998, 15 (2), 185–195.
  • Peptide-liposome association. A critical examination with mastoparan- X. HELLMANN, N., and SCHWARZ, G. Biochim. Biophys. Acta, 1998, 1369 (2), 267–277.
  • pH-metric logP 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs. AVDEEE, A., Box, K. J., COMER, J. E., HIBBERT, C., and TAM, K. Y. Pharm. Res., 1998, 15 (2), 209–215.
  • Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection. EMBI1EE, L., GELmoN, K., Tot.cnER, A., HunoN, N., HEGGIE, J., DEDHAR, C., LOGAN, P., BALLY, M. B., and MAYER, L. D. Cancer Chemother. Pharmacol., 1998, 41(5), 347–352.
  • Phenytoin sodium microcapsules: bench scale formulation, process characterization and release kinetics. VAZICI, E., ONER, L., KACS, H. S., and HiNcAL, A. A. Pharm. Dev. Technol., 1996, 1(2), 175–183.
  • Phosphatidylcholine liposomes as vehicles for disperse dyes for dyeing polyester/wool blends. MART, M., CODERCH, L., DE LA MAZA, A., MANIC, A., and PARRA, J. L. Text. Res. 1., 1998, 68 (3), 209–218.
  • Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrin. JIANG, F., LII.GE, L., GRENIER, J., Li, Y., Wtt.soN, M. D., and CEawr, M. Lasers Surg. Med., 1998, 22 (2), 74–80.
  • Photodynamic damage by liposome-bound porphycenes: comparison between in vitro and in vivo models. Tot.EDANo, H., EDREI, R., and KIWI., S. J. Photochem. Photobiol., B, 1998, 42(1), 20–27.
  • Photosensitization of cells with different metastatic potentials by liposome-delivered Zn(H)- phthalocyanine. VAI.DUGA,REDD', E., G katitsA, S., and Jolt', G. Int. I. Cancer, 1998, 75 (3),412–417.
  • Pipemidic acid-loaded chitosan microspheres produced by the spray-drying method. Btiio, M., BOGATAJ, M., and MRHAR, A. Adv. Chitin. Sci., 1997, 2, 519–524.
  • Placebo controlled trial of enteric-coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. BauNt), NI. J., HAvEtwact., E. B., TOSSEN, O. P., Tri•GAT, G. N. J., and VAN LUMEN, D. J. Gut, 1998, 42 (1), 92–96.
  • Platelet adhesion onto artificial surfaces: inhibition by benzamidine, pentamidine, and pyridoxa1-5-phosphate as demonstrated by flow cytometric quantification of platelet adhesion to microspheres. GENINIEI.I., C. H. 1. l.ab. Clio. Med., 1998, 131 ( I ), 84–92.
  • Polyorganophosphazene microspheres for drug release: polymer synthesis, microsphere preparation, in vitro and in vivo naproxen release. VEa()NEsE, F. NI., MARSILIO, F., CALK ETI, P., DE FILIPt,ts, P., GIUNCHEDI, P., and L(mA, S. I. Controlled Release, 1998, 52 (3), 227–237.
  • Post-kala-azar dermal leishmaniasis with mucosal involvement in a kidney transplant recipient: treatment with liposomal amphotericin B. RovsTAN, G'., JIMENEZ, J. A., GuTtEa-REz, S. B., GALLEut), J. L., ALVAR, J., and PATRON, NI. Br. .7. Dermatol., 1998, 138 (3), 526–528.
  • Preclinical evaluation of a sterically stabilized liposome-encapsulated cisplatin in clinically normal cats. THAMNI, D. H., and VA., D. M. Am. J. Vet. Res., 1998, 59 (3), 286–289.
  • Preparation and characterization of bifunctional biopolymers for receptor-based liposomal immunosensing. Yu, Y. Y., WIE, B. J. V., Kocti, A. R., MorrETT, D. F., and DAVIS, W. C. Biotechnol. Prog., 1998, 14 (2), 310–317.
  • Preparation and characterization of agarose hydrogel nanoparticles for protein and peptide drug delivery. WANG, N., and Wu, X. S. Pharm. Dev. Technol., 1997, 2 (2), 135–142.
  • Preparation and evaluation of glutaraldehyde crosslinked chitosan microspheres as a gadolinium reservoir for neutron-capture therapy. SAIIA, T. K., J()No, K., IcniKAwA, H., and FuRumat, Y. Chem. Pharm. Bull., 1998, 46 (3), 537–539.
  • Preparation and pharmacological evaluation of physostigmine-loaded polyisobutylcyanoa-crylate nanoparticles in rats. TSAI, T. R., Corn, W. H., LIN, C. W., and CnAm, T. M. Kao Hsiung I Hsueh Ko Hsueh Tsa Chili, 1998, 14 (1), 13–18.
  • Preparation and application of long-circulating liposomes for cancer chemotherapy. LINEZAKI, S., and HosoDA, J.-I. Pharm. Tech. jpn., 1998, 14 (2), 265–268. 271–273.
  • Preparation of silicone microspheres by emulsion polymerization: application to the encap-sulation of a hydrophilic drug. KEDZIEREWICZ, F., DARNIE, X., ETIENNE, A., LENIUT, J., HOFFMAN, M., and MAINCENT, P..7. Microencapsulation, 1998, 15 (2), 227–236.
  • Preparation and characterization of sustained-release microspheres of chlorpromazine. GA(), Z. G., OH, K. H., and KIM, C.Microencapsulation, 1998, 15 (1), 75–83.
  • Preparation and evaluation of microspheres prepared from whey protein isolate. HEIMAN, B. A., and CORRIGAN, 0.Microencapsulation, 1998, 15 (1), 93–105.
  • Preparation of liposome-encapsulating adenosine triphosphate. ARAKAWA, A., Istitut:at), S. I., Otim, K., and TAMA, M. Toholut 1. Exp. Med., 1998, 184 (1), 39–47.
  • Preparation of liposomes by a controlled assembly method. ZHANO, L., Hu, J., XIAO, Z., and Lu, Z. Mol. Cryst. Liq. Cryst. Sci. Technol., Sect. A, 1997, 295, 423–426.
  • Preparative conditions of PHB microspheres containing drug. CIIEN, H., ZHANG, H., and PANG, Y. liangsu Sht:you Huagong Xueyuan Xuebao, 1997, 9 (4), 15–18. 23.
  • Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. JANIEELA, S. R., KuntARY, T. V., LAL, A. V., and JAYAKRISIINAN, A..7. Controlled Release, 1998, 52 (1,2), 17–24.
  • Properties of acyclovir-containing liposomes for potential ocular delivery. LAW, S. L., and HuNG, H. Y. Int. J. Pharm., 1998, 161 (2), 253–259.
  • Prophylaxis against lipopolysaccharide-induced acute lung injury by alpha-tocopherol lipo-somes. SUNTI2ES, Z. E., and SHEK, P. N. Crit. Care Med., 1998, 26 (4), 723–729.
  • Protective effect of liposome encapsulation on paclitaxel developmental toxicity in the rat. SCIALLI, A. R., WATERHOUSE, T. B., DESESSO, J. M., RAHMAN, A., and GOP:RINGER, G. C. Teratology, 1997, 56 (5), 305–310.
  • Protein loss by the microencapsulation of an enzyme (lactase) in alginate beads. DASIIEVSKY, A. Int. J. Pharm., 1998, 161 (I), 1–5.
  • Pulmonary pharmacokinetics of cyclosporin A liposomes. ARPPE, J., VIDGREN, M., and WALDREP, J. C. Int. J. Pharm., 1998, 161 (2), 205–214.
  • Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. STEWART, S., JABLONOWSKI, H., GOF.BEL, F. D., ARASTEH, K., SPIT'FLE, M., Rios, A., ABOULAFIA, D., GALLESHAW, J., and DEZURE, B. J. J. Clin. Oncol., 1998, 16(2), 683–691.
  • Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection. LEITZKE, S., BUCKE, W., BORNER, K., MULLER, R., HAHN, H., and EHLERS, S. Antimicrob. Agents Chemother., 1998, 42(2), 459–461.
  • Recent advances in liposome technologies and their applications for systemic gene delivery. CHONN, A., and CuLLis, P. R. Adv. Drug Delivery Rev., 1998, 30 (1-3), 73–83.
  • Reference sample microsphere method to measure blood flow effects on small intestinal perfusion in the rat. WAHLBERG, E., and ENOCHSSON, L. Int. J. Microcirc. Clin. Exp., 1997, 17 (6), 330–336.
  • Sensitized liposomes as an antigen delivery system for the stimulation of mucosal immunity. VELEZ, C. N., TONKONOGY, S. L., LICHTNIAN, S. N., and Coo, M. .1. j. Drug Target., 1997, 5 (1), 15–24.
  • Simplified method to quantitate regional cerebral blood flow by 123I-IMP microsphere model: validity of input counts by using the whole brain time-activity curve and one point arterial blood sampling. INouE, T., FUJIOKA, H., IsFumAau, Y., AKANIUNE, A., MURASE, K., TNNADA, S., and IKEZOE, J. Kaku Igaku, 1998, 35 (1), 15–20.
  • Simultaneous determination of chlorzoxazorte, indicator of CYP2E1, and its metabolite in human serum using a new reversed-phase chromatographic column of 2-.mu.m porous microspherical silica-gel. TANAKA, E. J. Pharm. Biomed, Anal., 1998, 16(5), 899–904.
  • Singlet oxygen deactivation action of alpha-tocopherol in liposome membrane and determi-nation of reaction rate constants. FliKCIZAWA, K., MATSAURA, K., Thai, M., TOKFNII'RA, A., SHIBATA, A., Suzuki, A., and TERAO, J. Bitamin E Kenkyu no Shinpo, 1997, 7, 6–14.
  • Size dependence of polymer composition in the surface layer of poly(acrylamide-co-acrylic acid) hydrogel microspheres. NAGASHIMA, S., ANDO, S., MIKINO, K., TSUKAMOTO, T., and OIISHINIA, H. 1. Colloid Interface Sci., 1998, 197 (2), 377–382.
  • Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres. CIVIC, K., HINCAL, A. A., KAS, H. S., ERCAN, T. NI., SUNGUR, A., GUVEN, 0,, and RUACAN, S. Pharm. Dev. Technol., 1997, 2 (2), 151–160.
  • Solvent evaporation processes for the production of controlled release biodegradable micro-sphere formulations for therapeutics and vaccines. CLELAND, J. L. Biotechnol. Prog., 1998, 14 (1), 102–107.
  • Spontaneous liposome formation induced by grafted poly(ethylene oxide) layers: theoretical prediction and experimental verification. &LEIFER, I., GERASIMOV, 0. V., and TnompsoN, D. H. Proc. Natl. Acad. Sci. USA, 1998, 95 (3), 1032–1037.
  • Stability of alpha-amylase immobilized on poly(methyl methacrylate-acrylic acid) micro-spheres. AKSOY, S., TUNITURK, H., and HASIRCI, N. J. Biotechnol., 1998, 60 (1-2), 37–46.
  • Stability of liposomes prepared from Archaebacterial lipids and phosphatidylcholine mix-tures. SPROTT, G. D., DICAIRE, C. J., Fix.miNG, L. P., and PATEL, G. B. Cells Mater., 1996, 6 (1-3), 143–155.
  • Stabilization of small unilamellar dimyristoylphosphatidylcholine (DMPC)-liposomes by uncharged polymers. GROHNIANN, F. L., CZEMPESZ, F., and SzoGyi, M. Colloid Polym. Sci., 1998, 276 (1), 66–71.
  • Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Tomo, M., GREF, R., SANCHEZ, A., LANGER, R., and At.oNso, M. J. Pharm. Res., 1998, 15 (2), 270–275.
  • Stereoselective disposition of suspensions of conventional and wax matrix sustained release ibuprofen microspheres in rats. ADEYEYE, C. M., and CHEN, F. F. Pharm. Res., 1997, 14(12), 1811–1816.
  • Storage stability of stabilized MLV and REV liposomes containing sodium methotrexate (aqueous and lyophilized). SAtivoi.oulo, M. N., and TOLIAT, T. PDA y. Pharm. Sci. Technol., 1998, 52 (I), 23–27.
  • Studies on hyperthermia combined with arterial blockade for treatment of tumors: (Part II) effectiveness of hyperthermia combined with arterial embolization using degradable starch microspheres. MURATA, T., AKAGI, K., IMAMURA, M., NASU, R., KIMURA, H., NAGATA, K., and TANAKA, Y. Oncol. Rep., 1998, 5 (3), 705–708.
  • Study on rifampicin-poly(lactic acid) microspheres for lung targeting. I. Microsphere size and size distribution. ZHANG, C., and JIANG, X. Zhongguo Yiyuan Yaoxue Zazhi, 1997, 17 (5), 196–198.
  • Study on transdermal absorption mechanism of low molecular weight heparin liposomal spray gel. ZHAI, G., Zou, L., ZHANG, T., and ji, S. Shandong Yike Daxue Xuebao, 1997, 35 (2), 170–172.
  • Study on antitumor effect of IL-2 liposomes. PEI, J., YANG, C., YANG, H., and CFIEN, M. Zhongguo Yiyuan Yaoxue Zazhi, 1997, 17 (8), 361–363.
  • Study on microencapsulation of capsicum oleoresin. XIANG, Y., Liu, D., YANG, G., JiNu, P., and CHENG, M. Shipin Kexue (Beijing), 1997, 18(11), 27–30.
  • Study on rifampicin-poly(lactic acid) microspheres for lung targeting and in vitro release properties. ZHANG, W., and JIANG, X. Zhongguo Yiyuan Yaoxue Zazhi, 1997, 17 (10), 442–444.
  • Subsolubilizing alterations caused by alkyl glucosides in phosphatidylcholine liposomes. o. LA MAZA, A., CODERCH, L., GONZALEZ, P., and PARRA, J. L. y. Controlled Release, 1998, 52 (1,2), 159–168.
  • Successful treatment of mycotic hepatic artery pseudoaneurysms with arterial reconstruc-tion and liposomal amphotericin B. RUDICH, S. M., KINKHABWALA, M. M., MURRAY, N. G., SEE, D. M., BusuTril., R. W., and IMAGAWA, D. K. Liver Transpl. Surg., 1998, 4 (1), 91–93.
  • Successful treatment of severe refractory idiopathic thrombocytopenic purpura with liposo-mal doxorubicin. COSGRIFF, T. M., BLACK, M. L., and STEIN, W. III. Am. J. Hematol., 1998, 57(1), 85–86.
  • Surface charge control of electropermeabilization and glycophorin electroinsertion with 1,2-diacyl-sn-glycero-3-phosphocholine (lecithin) liposomes. RAFFY, S., and TEISSIF, J. Eur. J. Biochem., 1997, 250 (2), 315–319.
  • Surface modification of polyanhydride microspheres. GAO, J., NIKLASON, L., ZuAo, X. M., and LANGER, R. J. Pharm. Sci., 1998, 87 (2), 246–248.
  • Surface-modified amikacin-liposomes. Organ distribution, and interaction with plasma proteins. BUCKE, W. E., LEITZKE, S., DIEDERICHS, J. E., BURNER, K., HAHN, H., EHLERS, S., and MUELLER, R. H. y. Drug Targeting, 1998, 5 (2), 99–108.
  • Synthesis and study of the chromatographic properties of microspherical macroporous carboxylic cation exchangers based on (meth)acrylic acid. EMEL-YANOV, I. S., and CHERNYKH, G. P. Zh. Prikl. Khim. ( S. Peterburg), 1997, 70 (9), 1451–1454.
  • Synthesis of novel thiol-reactive amphiphilic lipids based on cholesterol for protein-liposome coupling. KLEY, J. T., FICHERT, T., and MASSING, U. Monatsh Chem., 1998, 129 (3), 319–327.
  • Synthesis of a new neoglycolipid (AgH-1) and its effect upon the properties of dipalmitoyl-phosphatidylcholine:cholesterol liposomes. Lissi, E. A., AKIN, E. B., LANIO, M. E., ALVAREZ, C., LUZARDO, M. C., FIGUEROA, S., and VEREZ, V. Arch. Biochem. Biophys., 1998, 350 (2), 137–144.
  • Synthesis of imprinted polymer microspheres capable of recognition of ions. Yu, K., UN, Y and YANG, D. Taiyuan Ligong Daxue Xuebao, 1998, 29 (1), 28–30. 34.
  • Targeted follicular delivery of macromolecules via liposomes. WEINER, N. Int. J. Pharm., 1998, 162 (1-2), 29–38.
  • Targeting of doxorubicin loaded liposomes to T-cells via the transferrin receptor. CORLEY, P., and LOUGFIREY, H. C. Biochem. Soc. Trans., 1998, 26 (1), S37.
  • Temperature-dependent associating property of liposomes modified with a thermosensitive polymer. HAYASHI, H., KONG, K., and TAKAGISILI, T. Bioconjugate Chem., 1998, 9 (3), 382–389.
  • Tertiary structural changes of the .alpha.-hemolysin from Staphylococcus aureus on associa-tion with liposome membranes. BOR'FOLETO, R. K., DE OLIVEIRA, A. H. C., RULLER, R., ARNI, R. K., and WARD, R. J. Arch. Biochem. Biophys., 1998, 351 (1), 47–52.
  • The development of IL-2 conjugated liposomes for therapeutic purposes. KONIGSBERG, P. J., GODTEL, R., KISSEL, T., and RICHER, L. L. Biochim. Biophys. Acta, 1998, 1370 (2), 243–251.
  • The use of 13C solid state NMR to elucidate physicochemical association in Eudragit RS100 microencapsulated acyl esters of salicylic acid. VACHON, M. G., and NAIRN, J. G. Eur. J. Pharm. Biopharm., 1998, 45 (1), 9–21.
  • The analysis of the insertion of UO2 microspheres in the gap between pellet and clad as a new design solution to increase the burnup of the nuclear fuel. MEHEDINTEANU, S. Nucl. Eng. Des., 1998, 179 (1), 1–16.
  • The C-terminal helix of human apolipoprotein Al promotes the fusion of unilamellar liposomes and displaces apolipoprotein AI from high-density lipoproteins. LAMBERT, G., DECOUT, A., VANLOO, B., ROUY, D., DUVERGER, N., KALOPISSIS, A., VANDEKERCKHOVE, J., CHAMBAZ, J., BRASSEUR, R., and ROSSENEU, M. Eur. J. Biochem., 1998, 253 (1), 328–338.
  • The delivery of angiogenic factors to the heart by microsphere therapy. ARRAS, M., MOLLNAU, H., STRASSER, R., WENZ, R., ITO, W. D., SCHAPER, J., and SCHAPER, W. Nat. Biotechnol., 1998, 16 (2), 159–162.
  • The effect of ionic strength on liposome-buffer and 1-octanol-buffer distribution coefficients. AUSTIN, R. P., BARTON, P., DAVIS, A. M., MANNERS, C. N., and STANSELD, M. C. J. Pharm. Sci., 1998, 87 (5), 599–607.
  • The effects of plasma and shear force on the stability of liposome encapsulated hemoglobin - in vitro testing. CHUNG, T. W., HWUNG, G. H., CHEN, W. K., and LEE, C. J. 5. Chin. Inst. Chem. Eng., 1997, 28 (6), 407–413.
  • The fundamental study of He-MIP-AES analysis as particle-by-particle measurement with Si02 monodispersed microsphere. SAITO, S., TSUGOSHI, T., FURUYA, K., KUDO, Y., MISHIMA, M., TAKAHARA, H., ADACHI, T., and SAKAI, K. Anal. Sci., 1997, 13 (Suppl., Asianalysis IV), 21–24.
  • The immunological co-adjuvant action of liposomal interleukin-2. The role of mode of localization of the cytokine and antigen in the vesicles. GuasEL, M., and GREGORIADIS, G. 5. Drug Targeting, 1998, 5 (2), 93–98.
  • The relationship between intrahepatic portal systemic shunts and microsphere induced portal hypertension in the rat liver. Li, X., BENJAMIN, I. S., and ALEXANDER, B. Gut, 1998, 42 (2), 276–282.
  • The synthesis and characterization of novel carboxyl telechelic microspheres. XIE, D. L., GE, H. X., ZHANG, L. X., and YANG, C. Z. 5. Appl. Polym. Sci., 1998, 68 (2), 205–216.
  • The effect of jet-milling on lyophilized liposomes. Mos:J.:N., W. C. Pharm. Res., 1998, 15 (1), 149–152.
  • The HVJ liposome method. ISAKA, Y., AKAGI, Y., KANEDA, Y., and Imm, E. Exp. Nephrol., 1998, 6 (2), 144–147.
  • The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs. OussosEN, C., ELAM:, \V. Ni. C., CROMMEIAN, D. J. A., STORM, G., and ZumEmA, J. Biochim. Biophys. Acta, 1998, 1369 (1), 159–172.
  • The interaction of liposomes with the complement system. SZEBENI, J. Crit. Rev. Ther. Drug Carrier Syst., 1998, 15 (1), 57–88.
  • The interaction of phospholipid liposomes with bacteria and their use in the delivery of bactericides. JONES, M. N., SONG, Y. H., KASZUBA, M., and REBOIRAS, Ni. D. 5. Drug Target., 1997,5 (1), 25–34.
  • The side effect and complication of intraarterial phosphorus-32 glass microspheres for patients with advanced hepatoma. Li, L., YAN, L., and CHIN, X. L. Shengwu Yixue Gongchengxue Zazhi, 1997, 14 (4), 370–379.
  • The structure of DNA complexes with cationic liposomes-cylindrical or flat bilayers? DAN, N. Biochim. Biophys. Acta, 1998, 1369 (1), 34–38.
  • Thermal analysis of freeze-dried liposome-carbohydrate mixtures with modulated tempera-ture differential scanning calorimetry. VAN WINDEN, E. C., TALSNIA, H., and CROMMELIN, D. J. y. Pharm. Sci., 1998, 87 (2), 231–237.
  • Thermal characteristics of supercooled phase change materials inside microcapsules. YAMAGISHI, Y., SuGENo, T., TAKEUCHI, H., and PYATENKO, A. T. Netsu Bussei, 1998, 12 (1), 10–17.
  • Thermochemotherapy using magnetic cationic liposomes and an anticancer drug. YANASE, NI., SHINKAI, M., Suzum, M., HONDA, H., and KoaArAsin, T. Kagaku Kogaku Ronbunshu, 1998, 24 (2), 179–183.
  • Time course of the cellular reaction toward microencapsulated xenogeneic islets in the rat. SIEBERS, U., HORCHER, A., BRANomasr, H., BRANDI-was-I', D., FEDERIAN, K., BRETZEL, R. G., and ZEKoaN, T. Transplant. Proc., 1998, 30 (2), 494–495.
  • Topical liposome targeting of dyes, melanins, genes, and proteins selectively to hair follicles. HOFFNIAN, R. Ni. 5. Drug Targeting, 1998, 5 (2), 67–74.
  • Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats. BoswELL, G. W., BEKERSKV, I., BUELL, D., HII,ES, R., and WALSH, T. J. Antimicrob. Agents Chemother., 1998, 42 (2), 263–268.
  • Toxocara canis in mice: are liposomes and immunomodulator able to enhance the larvicidal effect of the anthelmintic? VELEBNY, S., TOMASOVICOVA, 0., HRCKOVA, G., and DUI3INSKY, P. Helminthologia, 1997, 34 (3), 147–153.
  • Transmission electron microscopy and light scattering studies on the interaction of a nonionic/anionic surfactant mixture with phosphatidylcholine liposomes. Ns LA MAZA, A., CooEacn, L., LOPEZ, 0., and PARRA, J. L. Microsc. Res. Tech., 1998, 40 (1), 63–71.
  • Transplantation of microencapsulated syngeneic and xenogeneic (neonatal porcine) islets in nonobese diabetic mice. Ao, Z., SUAREZ, P. W. L., RAJOTTE, R. V., KORBUTT, G. S., FI„ASHNER, M., and RABINOVITCH, A. Transplant. Proc., 1998, 30 (2), 500.
  • Transplantation of allogeneicixenogeneic pancreatic islets containing coherent microcap-sules in adult pigs. CALAORE, R., BASTA, G., LUCA, G., BOSELLI, C., BUFALARI, A., GIUSTOZZI, G. M., GIALLETTI, R., MORICONI, F., and BRUNETTI, P. Transplant. Proc., 1998, 30(2), 482–483.
  • Tumor imaging with radiolabeled liposomes. OGIHARA, U. I., and HISHIGORI, H. Men'eki, Shuyo Kaku Igaku, 1995, 10 (2), 43–49.
  • Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. FOSTER, N., CLARK, M. A., JEPSON, M. A., and HIRST, B. H. Vaccine, 1998, 16 (5), 536–541.
  • Ultrasound-induced degradation of PLA and PLGA during microsphere processing. Influ-ence of formulation variables. REICH, G. Eur. J. Pharm. Biopharm., 1998, 45 (2), 165–171.
  • Use of phosphatidylcholine liposomes for correction of mitochondrial phospholipid composi-tion in the medulla oblongata and frontal lobes in hemorrhagic shock. LESKOVA, 0. F., and GDOVICHENKO, V. I. Bull. Exp. Biol. Med., 1997, 123 (4), 322–325.
  • Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles. HUSSAIN, N., and FLORENCE, A. T. Pharm. Res., 1998, 15 (1), 153–156.
  • Validation of a high-performance liquid chromatographic assay method for quantification of total vincristine sulfate in human plasma following administration of vincristine sulfate liposome injection. EMBREE, L., GELMON, K. A., TOLCHER, A. W., HUDON, N. J HEGGIE, J. R., DEDHAR, C., WEBB, M. S., BALLY, M. B., and MAYER, L. D. J. Pharm. Biomed. Anal., 16 (4), 675–687.
  • Viability studies of agarose microencapsulated islets of Langerhans from dogs. TASIiIRO, H., IWATA, H., WARNOCK, G. L., IKADA, Y., and TSUJI, T. Transplant. Proc., 1998, 30 (2), 490.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.